Salt-inducible kinase 1 influences Na+,K+-ATPase activity in vascular smooth muscle cells and associates with variations in blood pressure

Journal of Hypertension

Volumn 29, Issue 12, 2011, Pages 2395-2403

  Popov, Sergej ^a   Silveira, Angela ^a   Wågsäter, Dick ^a   Takemori, Hiroshi ^b   Oguro, Ryousuke ^c   Matsumoto, Sachiko ^d   Sugimoto, Ken ^c   Kamide, Kei ^c   Hirose, Takuo ^e   Satoh, Michihiro ^e   Metoki, Hirohito ^c   Kikuya, Masahiro ^e   Ohkubo, Takayoshi ^e,f   Katsuya, Tomohiro ^c,g   Rakugi, Hiromi ^c   Imai, Yutaka ^e   Sanchez, Fabio ^a   Leosdottir, Margret ^h   Syvänen, Ann Christine ⁱ   Hamsten, Anders ^a   Melander, Olle ^h   Bertorello, Alejandro M ^a   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b National Institutes of Biomedical Innovation   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^h LUND UNIVERSITY   (Sweden)

ⁱ UPPSALA UNIVERSITY   (Sweden)

Author keywords

Hypertension; salt sensitivity; vascular tonus

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINO ACID; ANTIHYPERTENSIVE AGENT; CYSTEINE; GLYCINE; MESSENGER RNA; PROTEIN KINASE; SALT INDUCIBLE KINASE 1; SERINE; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIHYPERTENSIVE THERAPY; AORTA; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CELL CULTURE; CELL LINE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; ENZYME ASSAY; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE PHENOTYPE CORRELATION; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN CELL; HYPERTENSION; HYPOTENSION; IMMUNOHISTOCHEMISTRY; JAPANESE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; SWEDEN; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING;

EID: 81355154789     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834d3d55     Document Type: Article

References (45)

1. Ji W, Foo JN, O'Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592-599.
2. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009, 41:666-676.
3. Intersalt Cooperative Research Group. Intersalt: An international study of electrolyte excretion and blood pressure. Results for 24 h urinary sodium and potassium excretion. BMJ. 1988; 297:319-321.
4. Lifton RP. Molecular genetics of human blood pressure variation. Science 1996; 272:676-680.
5. Ezzati M, Lopez AD, Rodgers A, Hoorn SV, Murray CJ. The Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-1360.
6. Elliott P, Walker LL, Little MP, Blair-West JR, Shade RE, Lee DR, Rouquet P, et al. Change in salt intake affects blood pressure of chimpanzees: Implications for human populations. Circulation 2007; 116:1563-1568.
7. Skrabal F, Herholz H, Neumayr M, Hamberger L, Ledochowski M, Sporer H, et al. Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. Hypertension 1984; 6:152-158.
8. Meneton P, Jeunemaitre X, de Wardener HE, Macgregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85:679-715.
9. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
10. Melander O, von Wowern F, Frandsen E, Burri P, Willsteen G, Aurell M, et al. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J. Hypertens 2007; 25:619-627.
11. Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension: Short review of the evidence. Hypertension 2003; 41: 1000-1005.
12. Guyton AC. Blood pressure control: Special role of the kidneys and body fluids. Science 1991; 252:1813-1816.
13. Blaustein MP, Zhang J, Chen L, Song H, Raina H, Kinsey SP, et al. The pump, the exchanger, and endogenous ouabain. Signaling mechanisms that link salt retention to hypertension. Hypertension 2009; 53:291-298.
14. Dahl LK, Heine M, Tassinari L. Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility toexperimental hypertension. J. Exp Med 1962; 115:1173-1190.
15. Wang Z, Takemori H, Halder SK, Nonaka Y, Okamoto M. Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat adrenal. FEBS Lett 1999; 453:135-139.
16. Becker W, Heukelbach J, Kentrup H, Joost HG. Molecular cloning and characterization of a novel mammalian protein kinase harboring a homology domain that defines a subfamily of serine/threonine kinases. Eur J. Biochem 1996; 235:736-743.
17. Yoshida K, Yamada M, Nishio C, Konishi A, Hatanaka H. SNRK, a member of the SNF1 family, is related to low K-induced apoptosis of cultured rat cerebellar granule neurons. Brain Res 2000; 873:274-282.
18. Kertesz N, Samson J, Debacker C, Wu H, Labastie MC. Cloning and characterization of human and mouse SNRK sucrose nonfermenting protein (SNF-1)-related kinases. Gene 2002; 294:13-24.
19. Jaleel M, McBride A, Lizcano JM, Deak M, Toth R, Morrice NA, et al. Identification of the sucrose nonfermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett 2005; 579:1417-1423.
20. Sjö ström M, Stenström K, Eneling K, Zwiller J, Katz AI, Takemori H, Bertorello AM. SIK1 is part of a cell sodium-sensing network that regulates active sodium transport through a calcium-dependent process. Proc Natl Acad Sci U S A 2007; 104:16922-16927.
21. Liu J, Zhu J-K. A calcium sensor homolog required for plant salt tolerance. Science 1998; 280:1943-1945.
22. Halfter U, Ishitani M, Zhu J-K. The arabidopsis SOS2 protein kinase physically interacts with and is activated by the calcium-binding protein SOS3. Proc Natl Acad Sci U S A 2000; 97:3735-3740.
23. Bertorello A, Zhu J-K. SIK1/SOS2 networks: decoding sodium signals via calcium-responsive protein kinase pathways. Pfluguers Arch 2009; 458:613-619.
24. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev 2000; 80:135-172.
25. Stenström K, Takemori H, Bianchi G, Katz AI, Bertorello AM. Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium ransport caused by a hypertension-linked mutation in human a-adducin. J. Hypertens 27: 2452-2457.
26. Efendiev R, Bertorello AM, Zandomeni R, Cinelli AR, Pedemonte CH. Agonist-dependent regulation of renal Na,K-ATPase activity is modulated by intracellular sodium concentration. J. Biol Chem 2002; 277:11489-11496.
27. Berglund G, Elmstahl S, Janzon L, Larsson SA. The Malmo Diet and Cancer Study. Design and feasibility. J. Intern Med 1993; 233:45-51.
28. Persson M, Hedblad B, Nelson JJ, Berglund G. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol 2007; 27:1411-1416.
29. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, et al. Long-term outcome of the Malmo preventive project: mortality and cardiovascular morbidity. J. Intern Med 2000; 247:19-29.
30. van 't Hooft FM, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A. Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 2001; 104:1223-1228.
31. Farrall M, Green FR, Peden JF, Olsson PG, Clarke R, Hellenius ML, et al. Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet 2006; 2:e72.
32. Hirose T, Hashimoto M, Totsune K, Metoki H, Hara A, Satoh M, et al. Association of (pro)renin receptor gene polymorphisms with lacunar infarction and left ventricular hypertrophy in Japanese women: The Ohasama study. Hypertens Res 2011; 34:530-535
33. Wågsä ter D, Zhu C, Bjö rck HM, Eriksson P. Effects of PDGF-C and PDGFD on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 2009; 202:415-423.
34. Lang RM,Bierig M, Devereux RB, Flachskampf FA, Foster E, PellikkaPA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc Echocardiogr 2005, 18:1440-1463.
35. Bradburn MJ, Deeks JJ, Altman DG. sbe24: metan - an alternative metaanalysis command. Stata Tech Bull 1998; 44:4-15.
36. Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, Hwang SJ, et al. FraminghAm. Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007; 8 (Suppl 1):S3.
37. Devereux RB, de Simone G, Ganau A, Koren MJ, Roman MJ. Left ventricular hypertrophy associated with hypertension and its relevance as a risk factor for complications. J. Cardiovasc Pharmacol 1993; 21: S38-S44.
38. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79:407-414.
39. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, et al. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A 2009; 106:226-231.
40. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: Implications for public health. Int J. Epidemiol 2009; 38:791-813.
41. RosellM, Hellenius M-L, de Faire U, Berglund L, Gustafsson I-B, Johansson G. Contribution of a manually coded part in an optically readable, precoded seven day food record for the intake of energy, nutrients and foods. Scand J. Nutr 2003; 47:123-131.
42. Guidelines. Chapter 1. Epidemiology of hypertension. Hypertens Res 2009, 32:6-10.
43. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J. Med 1997; 336:1117-1124.
44. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J. Med 2001; 344:3-310.
45. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 1991; 88:6259-6263.